Article thumbnail

Metabolic syndrome in patients with chronic hepatitis C virus genotype 1 infection who do not have obesity or type 2 diabetes

By Lucivalda Pereira Magalhães Oliveira, Rosangela P. de Jesus, Ramona SSB Boulhosa, Carlos Mauricio C. Mendes, Andre Castro Lyra and Luiz Guilherme C. Lyra
Topics: Clinical Science
Publisher: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
OAI identifier: oai:pubmedcentral.nih.gov:3297029
Provided by: PubMed Central

Suggested articles

Citations

  1. (2010). A language and environment for statistical computing.
  2. Abnormal liver function test results are related to metabolic syndrome and BMI in Taiwanese adults without chronic hepatitis B or C.
  3. (1992). Advances in body composition assessment. Current issues in exercise science series. Champaing: Human Kinetics;
  4. (2008). Clinical significance of metabolic syndrome in the setting of chronic hepatitis C virus infection. Clin Gastroenterol Hepatol.
  5. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study.
  6. (2005). Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids. Horm Metab Res.
  7. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol.
  8. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol.
  9. (2004). Hepatites virais: aspectos da epidemiologia e da prevenc ¸a ˜o. Rev Bras Epidemiol.
  10. Hepatitis C virus and type 2 diabetes.
  11. Hepatitis C Virus entry: the early steps in the viral replication cycle.
  12. Hepatitis C virus infection and metabolic syndrome—-a communitybased study in an endemic area of Taiwan.
  13. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
  14. Insulin resistance and liver fibrosis progression in patients with chronic hepatitis C virus infection.
  15. Insulin resistance and steatosis in hepatitis C virus infection.
  16. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.
  17. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis
  18. Metabolic disorders associated with chronic hepatitis C: impact of genotype and ethnicity. Liver Int.
  19. Metabolic syndrome, insulin resistance and adiponectin level in patients with chronic hepatitis C. J Gastrointestin Liver Dis.
  20. (2007). Ministe ´rio daSau ´de. Casos confirmados de Hepatite
  21. (2008). Organization. Initiative for Vaccine Research (IVR): Hepatitis C,
  22. (2008). Organization. Waist Circumference and Waist–Hip Ratio: Report of a WHO Expert Consultation. Geneva: World Health Organization (WHO);
  23. Oxidative stress in viral and alcoholic hepatitis. Free Radic Biol Med.
  24. Oxidative stress-related molecules and liver fibrosis.
  25. The metabolic syndrome—a new worldwide definition.
  26. Ultrasound scanning in the detection of hepatic fibrosis and steatosis.
  27. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample.
  28. Whole-body insulin sensitivity index is a highly specific predictive marker for virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients with genotype 1b and high viral load. Dig Dis Sci.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.